Trials / Sponsors / Cyclo Therapeutics, Inc.
Cyclo Therapeutics, Inc.
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | A 6-Month Study to Evaluate the Safety & Potential Efficacy of Trappsol Cyclo in Patients With Early Alzheimer Alzheimer's Disease | Phase 2 | 2022-09-23 |
| Active Not Recruiting | Phase 3 Study to Evaluate Intravenous Trappsol(R) Cyclo(TM) in Pediatric and Adult Patients With Niemann-Pick Niemann-Pick Disease, Type C1 | Phase 3 | 2021-07-20 |
| Unknown | Open-Label Study of Long-Term Safety and Efficacy of Intravenous Trappsol Cyclo (HPβCD) in Niemann-Pick Diseas Niemann-Pick Disease, Type C1 | Phase 1 | 2019-05-23 |
| Completed | Study of the Pharmacokinetics of Trappsol and Effects on Potential Biomarkers of Niemann-Pick C1 (NPC1) Niemann-Pick Disease, Type C1 | Phase 1 | 2017-10-11 |
| Completed | Safety and Efficacy of Intravenous Trappsol Cyclo (HPBCD) in Niemann-Pick Type C Patients Niemann-Pick Disease, Type C1 | Phase 1 / Phase 2 | 2017-03-20 |
| No Longer Available | Expanded Access With Trappsol(R) Cyclo (TM) for an Individual Patient With Late Onset Alzheimer's Disease Late Onset Alzheimer Disease | — | — |